Affiliations
AffiliationItem in Clipboard
Impact of mammography detection on the course of breast cancer in women aged 40-49 yearsJudith A Malmgren et al. Radiology. 2012 Mar.
. 2012 Mar;262(3):797-806. doi: 10.1148/radiol.11111734. AffiliationItem in Clipboard
AbstractPurpose: To analyze trends in detection method related to breast cancer stage at diagnosis, treatments, and outcomes over time among 40-49-year-old women.
Materials and methods: i This study was institutional review board approved, with a waiver of informed consent, and HIPAA compliant. A longitudinal prospective cohort study was conducted of women aged 40-49 years who had primary breast cancer, during 1990-2008, and were identified and tracked by a dedicated registry database (n = 1977). Method of detection--patient detected (PtD), physician detected (PhysD), or mammography detected (MamD)--was chart abstracted. Disease-specific survival and relapse-free survival statistics were calculated by using the Kaplan-Meier method for stage I-IV breast cancer.
Results: A significant increase in the percentage of MamD breast cancer over time (28%-58%) and a concurrent decline in patient and physician detected (Pt/PhysD) breast cancer (73%-42%) (Pearson x(2) = 72.72, P < .001) were observed over time from 1990 to 2008, with an overall increase in lower-stage disease detection and a decrease in higher-stage disease. MamD breast cancer patients were more likely to undergo lumpectomy (67% vs 48% of Pt/PhysD breast cancer patients) and less likely to undergo modified radical mastectomy (25% vs 47% of the Pt/PhysD breast cancer patients) (P < .001). Uncorrected for stage, 13% of MamD breast cancer patients underwent surgery and chemotherapy versus 22% of Pt/PhysD breast cancer patients (P < .001), and 31% of MamD breast cancer patients underwent surgery, radiation therapy, and chemotherapy versus 59% of Pt/PhysD breast cancer patients (x(2) = 305.13, P < .001). Analyzing invasive cancers only, 5-year relapse-free survival for MamD breast cancer patients was 92% versus 88% for Pt/PhysD patients (log-rank test, 12.47; P < .001).
Conclusion: Increased mammography-detected breast cancer over time coincided with lower-stage disease detection resulting in reduced treatment and lower rates of recurrence, adding factors to consider when evaluating the benefits of mammography screening of women aged 40-49 years.
© RSNA, 2012.
FiguresFigure 1:
Flow diagram.
Figure 1:
Flow diagram.
Figure 1:Flow diagram.
Figure 2:
Proportional change in detection method…
Figure 2:
Proportional change in detection method in women aged 40–49 years over time for…
Figure 2:Proportional change in detection method in women aged 40–49 years over time for years 1990–2008 (n = 1977).
Figure 3:
Number of cases according to…
Figure 3:
Number of cases according to detection method in women aged 40–49 years over…
Figure 3:Number of cases according to detection method in women aged 40–49 years over time for years 1990–2008 (n = 1977).
Figure 4:
Change in tumor stage for…
Figure 4:
Change in tumor stage for breast cancers diagnosed with all detection methods according…
Figure 4:Change in tumor stage for breast cancers diagnosed with all detection methods according to year of diagnosis over time for years 1990–2008 (n = 1977).
Figure 5:
Change in tumor stage for…
Figure 5:
Change in tumor stage for MamD breast cancer cases according to year of…
Figure 5:Change in tumor stage for MamD breast cancer cases according to year of diagnosis over time for years 1990–2008 (n = 865).
Figure 6:
Relapse-free survival after diagnosis according…
Figure 6:
Relapse-free survival after diagnosis according to detection method ( n = 1583).
Figure 6:Relapse-free survival after diagnosis according to detection method (n = 1583).
Figure 7:
Disease-specific survival after diagnosis according…
Figure 7:
Disease-specific survival after diagnosis according to detection method ( n = 1610).
Figure 7:Disease-specific survival after diagnosis according to detection method (n = 1610).
Figure 8:
Overall survival after diagnosis according…
Figure 8:
Overall survival after diagnosis according to detection method ( n = 1627).
Figure 8:Overall survival after diagnosis according to detection method (n = 1627).
Similar articlesMalmgren J, Atwood M, Kaplan H. Malmgren J, et al. Breast J. 2012 May-Jun;18(3):257-60. doi: 10.1111/j.1524-4741.2012.01231.x. Epub 2012 Apr 5. Breast J. 2012. PMID: 22487162
Malmgren JA, Parikh J, Atwood MK, Kaplan HG. Malmgren JA, et al. Radiology. 2014 Dec;273(3):686-94. doi: 10.1148/radiol.14140209. Epub 2014 Aug 5. Radiology. 2014. PMID: 25093690
Kaplan HG, Malmgren JA, Atwood MK. Kaplan HG, et al. BMC Cancer. 2020 Nov 20;20(1):1124. doi: 10.1186/s12885-020-07609-3. BMC Cancer. 2020. PMID: 33218313 Free PMC article.
Robertson C, Arcot Ragupathy SK, Boachie C, Dixon JM, Fraser C, Hernández R, Heys S, Jack W, Kerr GR, Lawrence G, MacLennan G, Maxwell A, McGregor J, Mowatt G, Pinder S, Ternent L, Thomas RE, Vale L, Wilson R, Zhu S, Gilbert FJ. Robertson C, et al. Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322. doi: 10.3310/hta15340. Health Technol Assess. 2011. PMID: 21951942 Free PMC article. Review.
[No authors listed] [No authors listed] Prescrire Int. 2013 Dec;22(144):298-303. Prescrire Int. 2013. PMID: 24600734 Review.
Tabár L, Dean PB, Chen TH, Yen AM, Chen SL, Fann JC, Chiu SY, Ku MM, Wu WY, Hsu CY, Chen YC, Beckmann K, Smith RA, Duffy SW. Tabár L, et al. Cancer. 2019 Feb 15;125(4):515-523. doi: 10.1002/cncr.31840. Epub 2018 Nov 8. Cancer. 2019. PMID: 30411328 Free PMC article.
Lipscomb J, Fleming ST, Trentham-Dietz A, Kimmick G, Wu XC, Morris CR, Zhang K, Smith RA, Anderson RT, Sabatino SA; Centers for Disease Control and Prevention National Program of Cancer Registries Patterns of Care Study Group. Lipscomb J, et al. Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):613-23. doi: 10.1158/1055-9965.EPI-15-0225. Epub 2016 Jan 27. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26819266 Free PMC article.
Heinig M, Heinze F, Schwarz S, Haug U. Heinig M, et al. BMC Cancer. 2022 Feb 2;22(1):130. doi: 10.1186/s12885-022-09240-w. BMC Cancer. 2022. PMID: 35109813 Free PMC article.
Bennett DL, Winter AM, Billadello L, Lowdermilk MC, Doherty CM, Kazmi S, Laster S, Al-Hammadi N, Hardy A, Kopans DB, Moy L. Bennett DL, et al. Breast Cancer Res Treat. 2024 Jan;203(2):215-224. doi: 10.1007/s10549-023-07092-x. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878149
Tait SD, Ren Y, Horton CC, Oshima SM, Thomas SM, Wright S, Caesar A, Plichta JK, Hwang ES, Greenup RA, Rosenberger LH, DiLalla GD, Menendez CS, Tolnitch L, Hyslop T, Nelson D, Fayanju OM. Tait SD, et al. Cancer. 2021 Jul 15;127(14):2515-2524. doi: 10.1002/cncr.33473. Epub 2021 Apr 7. Cancer. 2021. PMID: 33826758 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3